semaglutide quit smoking (Ozempic) found to treat addiction Ozempic linked to less tobacco-related
Description
Following several incident reports, the Therapeutic Goods Administration issued new precautions linked to these popular therapies.
In terms of switching, 22.9% of the GLP-1 receptor agonist users and 2.1% of the SGLT2 inhibitor users switched between drugs within the same drug class
Insurance coverage for GLP-1 drugs like Ozempic, Wegovy, and Zepbound is changing in 2026
Explore the evidence, side effect management tips, and UK clinical guidance for this investigational once-weekly injectable therapy.
